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A new 56 kDa actin-binding protein (ASP-f6) was isolated from pig platelet lysate. In falling ball viscosimetry it causcxt a reduction in viscosity 
that could be attributed to a decrease in the concentration of polymeric actin. Fluorescence measurements with NBD.labelled actin showed 
reduction of polymeric actin, too. These results could be explained by sequestering of actin in a non-polymerizabl¢ 1:1ASP-56/ectin complex. 
Sequencing of about 20 tryptic peptides of ASP-56 and comparison with known sequences revealed about 60% homology to the adenylate 
cyclase-associated protein (CAP) from yeast. 
Actin-sequestering protein; Actin; Adenylate cyela~e-associated protein 
1. INTRODUCTION 
The actin cytoskeleton of platelcts is known to un- 
dergo a dramatic change in organisation during activa- 
tion [1]. In resting platelets 40-60% o1' the actin are 
monomeric [2]. At the end of the activation cascade, 
however, most of the actin is filamentous. A number of 
proteins have been isolated which seem to play an active 
part in the organisation of actin filaments [3]. Among 
these proteins are profilin and thymosin ,84, which se- 
quester actin molecules in a non-polymerizable 1:1 com- 
plex [4,5], and gelsolin, which acts as a nucleus for actin 
polymerization in a calcium-dependent manner [6]. In 
this paper we report the isolation era new agtin binding 
protein, ASP-56, from pig platelets, and its charac- 
terization by actin-binding assays and partial sequence 
analysis. 
2. MATERIALS AND METHODS 
2.1. Isolation of ASP.SO 
Isolation of platelets from fresh pig blood was performed according 
to [7] with the minor modification that a fixed allele rotor was reed 
to prepare platelet rich plasma. 
About 12 8 of platelets was resuspended in 30 ml of 10 mM Tris, 
pH 8, 70 mM KCl, 0.1 mM EDTA. Protease inhibitors were added 
to a final concentration f 2.5/zNml lcapeptin, 2 U/ml aprotonin and 
0.1 mM PMSF. A double volume of ice-cold lysis buffer, containing 
10 mM Tris, pH 8, 0.1 mM EDTA, 200 mg/ml digitonin, 10 raM 
EGTA was added. The suspension was gantly mixed, left on ice for 
10 rain and then centrifuged at 100,000 x g for 1 h. The supernatant 
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was applied to a DE-52 column (2 × 40 cm) equilibrated with l0 raM 
Tris, pH 8, 30 mM KCI, 0,1 mM EDTA. The column was washed 
with one column volume of the same buffer, followed by a gradient 
from 0.03-0.3 M KCl (total volume 500 ml). The protein elated as a 
complex with actin at 100 mM KCi. Pooled fractions were dialysed 
again,;t 50 mM Tris, pH 8, 0.1 mM EDTA, 0.02% NaT~l 3and applied 
to a Pl I column (i x 20 cm) equilibrated with the same buffer. ASP- 
56/actin complex, like most of the smaller and less basic proteins, did 
not bind to the column. The flowthroagh was collected and diulysed 
against 0.6 M KCI, 0.1 mM EDTA, 10 mM Tris, pH 8, 0.1 mM D'l'r, 
0.1 mM PMSF, 1 mM benzamidine, 0.02% NAN,. The proteins were 
then concentrated with an amicon filtration cell (YM 30 membrane) 
axed applied to a CL-6B g¢lfiltration column (2 x 90 cm) equilibrated 
with the same buffer. ASP-56/actin complex eluted before the bulk 
protein. Pooled fractions were dialysed against 10 mM phosphate 
buffer (PB), pH 7.5, 0.1 mM EDTAo 0.02% NaN~ and applied to a 
hydroxyapatite column (1 x 10 cm) equilibrated with the same buffer. 
The column was washed with one column volume. Actin was sop. 
arated from ASP-56 by ¢lution with 3 M urea, 10 mM PB, pH 7.5, 0.1 
mM EDTA for 6 h. ASP-56 was elated with a Bradient from 10 mM 
to 0.5 M PB in 3 M urea (total volume 400 ml). ASP-56 elated at 0.2 
M PB and was then dialysed extensively against 100 mM KCi, 0.1 mM 
EDTA, 10 mM Tris, pH 8, 1 mM benzamidine, 0.1 mM PMSF, 
0,02% NaN~ and 0.1 mM DTT. The yield was around 0.5 nag from 
12 g platelets. 
2.2, Isolation of other proteins 
Actin was prepared according to [8]. Part of the preparation was 
labeled with NBD-CI according '.o [9]. Geisolin was isolated from pig 
platclets according to [10], 
2.31 Analytical methods 
Actin concentration was determined photometrically with an 
absorption coefficient of 0.64 for 1 mg/mi at 290 nm [11]. The con- 
centrations ofASP-56 and gcisolin were determined by the method of 
[121. 
Falling-ball viscosimetry was done according to [13]. 100/Jl ,glass 
capillaries (Brand) were filled with aetin and ASP.56 or geisolin under 
polymerization conditions (80 mM KCI, 2 ram MgCI2, 0.2 mM CaCl2: 
0.5 mM ATP, 0.2 mM D'I'I', 10 mM Tris, pH 7.5. ARcr 0.5 of 
polymerization capillari~ were tilted (30*) and a stainles teel ball 
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Fig. 1. Isolation of ASP-56 documented by SDS-PAGE. (Lane a) 
supernatant after ccnlrifugation of platelet lysate; (lane b) pooled 
fraction after DE-52 chromatography; (lane c) protein not bound to 
a PI I column; (lane d) pooted fractions after CL-6B gelfiltration; (lane 
e) isolated protein after hydroxyapatitc chromatography. 
(New England Miniature Ball Co., Norfolk, USA) was run through 
the capillary. The run was measured by light barriers. 
Fluorescence measurements were done with a Spex 1681 0.22 m 
Double Spectrometer operued by a Fast PC. One-tenth PJBD-actin 
was mixed with unlabeled actin. Polymeri?ztion was induced by 80 
mM KCI, 2 mM MgCIz, 0,2 mM CaC&, 0.5 mM ATP, 0.2 mM DTT, 
10 mM Tris, pH 7.5. Fluorescence excitation wavelength was 480 nm 
and emission wavelength was 540 nm. The portion of polymeric acrin 
was calculated irectly from the increase of tluorcscence intensity [9]. 
Binding of ASP-56 to actin did not change the fluoresccncc of the 
NBD label. 
SDS-polyacrylamide mini slab gel electrophoresis was performed 
according to [I4]. Molecular mass markers were from Bio-Rad 
(Munich, Gcrmany1. The gels were stained with Coomassie blue R- 
250. 
2.4. Cleavage of ASP-56, iddon of yeptidw and scqumce analysis 
The lyophilizd protein was dissolved in 0.1 M Tris-HCI, pH 8.5, 
containing 6 M guanidine hydrochloride, reduced with dithiothreitol 
(Anal concentration 2 mM) under nitrogen for 6 h at room tempera- 
ture and carboxymcthylatcd with iodoacetic acid (final concentration 
10 mM) under nitrogen at room temperature ovcrnigh~. The carboxy- 
methylated protein was precipitated with IO vols. ethanol overnight 
at -1iYC. The precipitate was solubilizcd in a small volume of 8 M 
urea and diluted with 0.2 M ammonium hydrogen carbonate to I M 
urea. The dissolved protein was thencleaved with 2yg trypsin (TPCK- 
treated. Worthington) overnight at 23°C. The reaction mixture was 
acidified to pH 2 with xilluoroacctic acid and the peptides were 
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Fig. 2. (a) Histogram of the run times of falling.ball viscosimctry of 
polymerized actin with different concentrations of ASP-56 Poly- 
merization conditions are described in Materials and Methods. The 
bars indicate the standard eviation of three parullel measuremtrtLs. 
(b) Histogram of the run times of the ball through actin networks of 
diflerent concentrations ofactin. (c) Falling-ball viscosimetry ofactin 
with various concentrations of gelsolin. 
separated by reversed phase chromatography on a C1S column 
(Vydac, 4.6 x 250 mm) using 0. I % trifluoroacetic acid (solvent A) and 
70% acetonitrilc in 0.1% trilluoroacetic acid (solvent B) with a 
gradient from O-60% B in I60 min and from 60-958 B in 40 min. The 
llow rate was 0.25 ml/min. The peptides were sequenced with a gas- 
liquid phase sequencer (Applied Biosystems, models 470A and 473A) 
following the manufacturer’s instructions, Sequence comparisons 
were done with the FASTP programme [IS] using the Martinsried 
Institute for Protein Sequences (MIPS) datu collection. 
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Fig. 3. (a) lncretlsc of polymeric actin during the polymerization time 
as measured with NBD-actin. (Lines a-f) 3 ,uM actin under poly- 
merisation condilions wilh difkrcnt coIlcenlralions Of ASP-56: (a) 0 
PM ASP-56; (b) 0.37 ,uM; (c) 0.74 @I; (d) I .I I PM; (c) I.45 yM; (r, 
9.74pM. (b) Plot of polymeric actin after 05 h polymerization against 
the ratio of ASP-56 to actin. Data were derived from the upper 
diagram. 
3. RESULTS AND DISCUSSION 
ASP-5G was purified from pig platelets .by a combina- 
tion of ion exchange, size exclusion and hydroxyapatite 
chromatography (Fig. I). Since ASP-56 co-purified with 
actin until treated with 3 M urea, we tested its in vitro 
binding activity by falling ball viscosimetry (Fig. 2a). A 
decrease in viscosity with increasing amounts of the 
isolated protein added to 3 $4 actir; was observed. I:: 
a control experiment he viscosity of decreasing con- 
centrations of actin was measured (Fig. 2b). When the 
concentration of ASP-56 was subtracted from the total 
actin concentration, both histograms became similar. 
This suggested that ASP-56 decreases the concentration 
of polymerized actin by sequestering actin in a non- 
polymerizable complex. 
Gelsolin, another actin filament severing and nuclcat- 
ing protein, showed a much higher activity in this assay 
than ASP-56. At a ratio of one gelsolin to 2,000 actin 
molecules a substantial decrease in viscosity could be 
observed (Fig. 2~). This can be attributed to the nucleat- 
ing activity of gelsolin. In comparison, the ASP-56 
seems to sequester actin monomers and has no nucleat- 
ing activity 1163. 
In a second assay, the actin sequestering activity of 
this protein was tested with actin labeled by a iluo- 
rescent dye. Fig. 3a shows the effect of ASP-56 on the 
time-course of actin polymerization. The time-course 
of polymerization revealed an initial lag phase. This 
provides additional evidence that ASP-56 has no- 
nucleating activity [171. 
In Fig. 3b the concentration of polymerized actin (0.5 
h polymerization time) is plotted against the ratio of 
ASP-56 to actin. With increasing amounts of ASP-56 
the portion of polymeric actin decreases. The plot shows 
a linear decrease of polymerized actin with increasing 
concentrations of ASP-56. At a ratio of one ASP-56 
molecule per one actin molecule polymerization is 
nearly completely inhibited. Taken together these 
results demonstrate hat ASP-56 is an actin sequestering 
protein which binds actin in a I:1 stoichiometry. 
In order to test whether the protein was already 
known from other tissues or species, it was partially 
sequenced. Since the N-terminus was found to be 
Table I 
Sequences of the peptidcs in single letter code 
TZi (X GPVAK 
T?b (VLX 
T3 (A)Q S G ? V R 
T4 IEYKDVDK 
TSa (T)H K N P AID)K 
TSb (El1 G G D V L(K) 
T6 IK W R 
‘r7ti IH V A D D(E)K 
Tlh (U F K Y 
7-8 (5 A El!-l)V H T G L K 
T9 lXASKPGISPS?KPVTK 
711 (LEAVSf!ASDTHYGYGDSA(AK) 
T12 II N S I ‘r V 9 N Y K 
r14 (XIWNGQK 
T15 (SVNSTLQIX 
f16 (XGPKPFSASKPGISPSXKPV 
l-18 (NSLDCEIVSAK 
T2Ol'l (ELSGLPSGPSAGSGPFPtP) 
T24 (VPXISINKXDGRHIYLSK 
T25 fXENXENVSNLVID(D)TELK 
T26/27 ISALFAOINQGESITHHLK 
-l-28/30 (S(SIE M N ‘J L I P(T)E G G D F N E F P V P E Q % % 
Uncertain assignments are in brackets. X = unidcnlified residues. 
Numberin reiers to Fig. 4. 
I51 
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Fig. 4. Tryptic peptides of ASP-56 separated by reversed phase chromatography. 
blocked, the denatured, reduced and carboxymethy- 
lated protein was cleaved with trypsin and the resulting 
peptides were separated by reversed phase chromatog- 
raphy (Fig. 4). The sequences of the proteolytic frag- 
ments chosen for sequence analysis are shown in Table 
I. A search for homologous sequences in the MIPS 
database with the FASTP programme showed a high 
percentage of identical amino acids between the long 
ASP-56 peptides T24 and T28 and a recently sequenced 
yeast protein CAP 70 [18], which had been shown to be 
an adenylate cyclase-associated regulatory protein. 
Since there was no other homology to a known protein 
we tried to align the other peptides to the CAP sequence 
(Fig. 5). Most of the ASP-56 peptides could in fact be 
aligned with some confidence: only few very short ones 
Fig. 5. Comparison of the amino acid sequences ofthe tryptic pptides 
of ASP-56 with CAP from Succharomyces c~~isiue. 
did not match to the yeast sequence. Introducing a few 
limited gaps, we obtained 62% identical residues for the 
alignment shown in Fig. 6. Considering the evolution- 
ary distance between yeast and pig we believe that these 
proteins are related. 
The homology of this actin-birding protein to the 
yeast adenyiate cyclase-associated protein raises the 
question of whether ASP-56, too, influences adenylate 
cyclase activity. This is currently under investigation. 
Field et al. [IS] showed that yeast mutants lacking CAP 
also expressed phenotypes which seemed to be unre- 
lated to effects due to the adenylate cyclase system. 
They found a swollen cell morphology, which could be 
due to cytoskeleton rearrangements. They also ob- 
served unusually large yeast cells hinting probably at 
some disturbance of the budding process, which is also 
known to depend on the cytoskeletnn [19]. Therefore we 
have to consider the possibility that ASP-56, which has 
been isolated as actin-binding protein from pig platelets, 
is also acting on the adenylate cyclase pathway, while 
the yeast homologue, discovered as adenylate cyclase- 
binding protein may also act on the yeast cytoskeleton, 
possibly via actin binding. 
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